{"id":"https://openalex.org/W7072044440","doi":null,"title":"Treatmentof ApoE Tokyo(Arg25Cys) mutant lipoprotein nephropathy with Benzabate in a child:a case report","display_name":"Treatmentof ApoE Tokyo(Arg25Cys) mutant lipoprotein nephropathy with Benzabate in a child:a case report","publication_year":2020,"publication_date":"2020-01-01","ids":{"openalex":"https://openalex.org/W7072044440"},"language":"zh","primary_location":{"id":"pmh:oai:doaj.org/article:cb01e1e76add45f09516934dc5abeb60","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/cb01e1e76add45f09516934dc5abeb60","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Linchuang shenzangbing zazhi, Pp 433-436 (2020)","raw_type":"article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["doaj"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"QIU Lian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"QIU Lian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"XIONG Jia-chuan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"XIONG Jia-chuan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.45190685,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apolipoprotein-e","display_name":"apolipoprotein E","score":0.7710000276565552},{"id":"https://openalex.org/keywords/hyperlipidemia","display_name":"hyperlipidemia","score":0.5899999737739563},{"id":"https://openalex.org/keywords/nephrotic-syndrome","display_name":"nephrotic syndrome","score":0.9129999876022339},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.8529999852180481},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.4860000014305115},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.5830000042915344}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6868000030517578},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.5509999990463257},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5349000096321106},{"id":"https://openalex.org/C2781184683","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Nephropathy","level":3,"score":0.5196999907493591},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4629000127315521},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.4571000039577484},{"id":"https://openalex.org/C57089818","wikidata":"https://www.wikidata.org/wiki/Q424728","display_name":"Apolipoprotein E","level":3,"score":0.41920000314712524},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.41179999709129333},{"id":"https://openalex.org/C2776104379","wikidata":"https://www.wikidata.org/wiki/Q21112670","display_name":"Lipoprotein(a)","level":4,"score":0.3465000092983246},{"id":"https://openalex.org/C2779620165","wikidata":"https://www.wikidata.org/wiki/Q28749","display_name":"Low-density lipoprotein","level":3,"score":0.2703999876976013}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:doaj.org/article:cb01e1e76add45f09516934dc5abeb60","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/cb01e1e76add45f09516934dc5abeb60","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Linchuang shenzangbing zazhi, Pp 433-436 (2020)","raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3031852062","https://openalex.org/W2081285898","https://openalex.org/W2085824144","https://openalex.org/W4403656948","https://openalex.org/W2475030669","https://openalex.org/W2844896497","https://openalex.org/W2164888275","https://openalex.org/W2909849386","https://openalex.org/W159803979","https://openalex.org/W4392382418"],"abstract_inverted_index":{"<\u6b63>\u8102\u86cb\u767d\u80be\u75c5(Lipoprotein":[0],"glomerulopathy,LPG),1989":[1],"\u5e74\u9996\u6b21\u7531\u65e5\u672c\u5b66\u8005Saito\u62a5\u9053,LPG\u4e3b\u8981\u7d2f\u53ca\u80be\u810f,\u4e14\u4ee5\u80be\u5c0f\u7403\u75c5\u53d8\u4e3a\u4e3b[1]\u3002\u51e0\u4e4e\u6240\u6709\u60a3\u8005\u5747\u6709\u4e0d\u540c\u7a0b\u5ea6\u7684\u86cb\u767d\u5c3f,\u591a\u6570\u8868\u73b0\u4e3a\u80be\u75c5\u7efc\u5408\u5f81,\u5c11\u6570\u8868\u73b0\u4e3a\u8f7b\u5fae\u86cb\u767d\u5c3f\u548c\u955c\u4e0b\u8840\u5c3f,\u90e8\u5206\u60a3\u8005\u4f34\u6709\u4e0d\u540c\u7a0b\u5ea6\u7684\u8d2b\u8840\u53ca\u9ad8\u8840\u538b,\u8840\u8102\u5f02\u5e38\u6613\u88ab\u5ffd\u7565\u4e3a\u80be\u75c5\u7efc\u5408\u5f81\u7684\u4f4e\u86cb\u767d\u8840\u75c7\u6240\u81f4\u3002\u8f7d\u8102\u86cb\u767dE(apolipoprotein":[2],"E,ApoE)\u589e\u9ad8\u662fLPG":[3],"\u8840\u8102\u6539\u53d8\u7684\u4e3b\u8981\u7279\u70b9[2-3]\u3002LPG":[4]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2025-10-10T00:00:00"}